Cargando…
Identification of cardioprotective drugs by medium-scale in vivo pharmacological screening on a Drosophila cardiac model of Friedreich's ataxia
Friedreich's ataxia (FA) is caused by reduced levels of frataxin, a highly conserved mitochondrial protein. There is currently no effective treatment for this disease, which is characterized by progressive neurodegeneration and cardiomyopathy, the latter being the most common cause of death in...
Autores principales: | Palandri, Amandine, Martin, Elodie, Russi, Maria, Rera, Michael, Tricoire, Hervé, Monnier, Véronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078405/ https://www.ncbi.nlm.nih.gov/pubmed/29898895 http://dx.doi.org/10.1242/dmm.033811 |
Ejemplares similares
-
A Yeast/Drosophila Screen to Identify New Compounds Overcoming Frataxin Deficiency
por: Seguin, Alexandra, et al.
Publicado: (2015) -
Impact of Drosophila Models in the Study and Treatment of Friedreich’s Ataxia
por: Monnier, Véronique, et al.
Publicado: (2018) -
Drosophila melanogaster Models of Friedreich's Ataxia
por: Calap-Quintana, P., et al.
Publicado: (2018) -
A New, Discontinuous 2 Phases of Aging Model: Lessons from Drosophila melanogaster
por: Tricoire, Hervé, et al.
Publicado: (2015) -
Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893)